Tandem Diabetes Care (TNDM) Other Working Capital Changes (2018 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Other Working Capital Changes came in at -$495000.0 in Q2 2026, down 114.54% on a YoY basis from $3.4 million in Q2 2025, and down 102.61% quarter-over-quarter from $19.0 million in Q1 2026.
Analysis
Tandem Diabetes Care (TNDM) Other Working Capital Changes (2018 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has reported Other Working Capital Changes for 14 consecutive years, with -$495000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Working Capital Changes fell 114.54% year-over-year to -$495000.0; the trailing twelve-month figure through Jun 2026 stood at $29.3 million (up 38.2% YoY), and the FY2025 full-year result was $19.2 million, up 9.25% from the prior year.
- Other Working Capital Changes retreated to -$495000.0 in Q2 2026 per TNDM's latest filing, from $19.0 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $11.5 million in Q4 2023 and bottomed at -$31.1 million in Q4 2024.
- Historically, Other Working Capital Changes has averaged -$745722.2 across 5 years, with a median of -$529000.0 in 2024.
- The sharpest annual moves came in 2022 and 2023: Other Working Capital Changes jumped 1145.35% in 2022, then sank 240.88% in 2023.
- Over 5 years, Other Working Capital Changes stood at $1.1 million in 2022, then tumbled by 240.88% to -$1.6 million in 2023, then soared by 766.19% to $10.7 million in 2024, then plunged by 33.78% to $7.1 million in 2025, then tumbled by 106.99% to -$495000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$495000.0, $19.0 million, and $7.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.27 Bn | 811.05 Mn | 144.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.70 Mn |
| Jun 30, 2026 | -2.70 Mn |
| Mar 31, 2026 | -1.08 Mn |
| Mar 31, 2026 | -1.08 Mn |
| Dec 31, 2025 | -686,000.00 |
| Dec 31, 2025 | -686,000.00 |
| Sep 30, 2025 | -1.39 Mn |
| Sep 30, 2025 | -1.39 Mn |
| Jun 30, 2025 | -1.11 Mn |
| Jun 30, 2025 | -1.11 Mn |
| Mar 31, 2025 | -1.60 Mn |
| Mar 31, 2025 | -1.60 Mn |
| Dec 31, 2024 | -31.15 Mn |
| Dec 31, 2024 | -31.15 Mn |
| Sep 30, 2024 | -2.33 Mn |
| Sep 30, 2024 | -2.33 Mn |
| Jun 30, 2024 | -889,000.00 |
| Jun 30, 2024 | -889,000.00 |
| Mar 31, 2024 | -372,000.00 |
| Mar 31, 2024 | -372,000.00 |